FDA Approves Apalutamide (Erleada); the first treatment for non-metastatic castration-resistant prostate cancer (READ MORE HERE).
Metabolic oxidative phosphorylation (OXPHOS) is a biochemical..
Joseph Ippolito, MD, PhD:
Washington University School of Medicine in St. Louis
Jeffrey Arbeit, MD; Farrokh Dehdashti, MD
Characterizing and Imaging Metabolic Symbiosis in Castrate- Resistant Prostate Cancer